Evotaz is a single film-coated tablet that contains atazanavir (300 mg) plus the booster cobicistat (150 mg).
- Standard dose is one tablet, once-daily.
- Evotaz needs to be taken with food to further increase levels of atazanavir.
- For more details please see informations about each drug: atazanavir and cobicistat.
- Link to leaflet about drug interactions between Evotaz and other medications (PDF)
Evotaz was approved in the EU and the US in January 2015.
Evotaz is not routinely available yet in the UK.
Link to US prescribing information package insert.
Link to US pateint information leaflet. (PDF)